Matter, Journal Year: 2025, Volume and Issue: unknown, P. 102095 - 102095
Published: April 1, 2025
Language: Английский
Matter, Journal Year: 2025, Volume and Issue: unknown, P. 102095 - 102095
Published: April 1, 2025
Language: Английский
Advanced Materials, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 2, 2025
Abstract Despite improvements in cancer survival rates, metastatic and surgery‐resistant cancers, such as pancreatic cancer, remain challenging, with poor prognoses limited treatment options. Enhancing drug bioavailability tumors, while minimizing off‐target effects, is crucial. Metal–organic frameworks (MOFs) have emerged promising delivery vehicles owing to their high loading capacity, biocompatibility, functional tunability. However, the vast chemical diversity of MOFs complicates rational design biocompatible materials. This study employed machine learning molecular simulations identify suitable for encapsulating gemcitabine, paclitaxel, SN‐38, identified PCN‐222 an optimal candidate. Following loading, MOF formulations are improved colloidal stability biocompatibility. In vitro studies on cell lines shown cellular internalization, delayed release. Long‐term tests demonstrated a consistent performance over 12 months. vivo tumor‐bearing mice revealed that paclitaxel‐loaded PCN‐222, particularly hydrogel local administration, significantly reduced spread tumor growth compared free drug. These findings underscore potential effective system hard‐to‐treat cancers.
Language: Английский
Citations
1Coordination Chemistry Reviews, Journal Year: 2025, Volume and Issue: 535, P. 216669 - 216669
Published: March 29, 2025
Language: Английский
Citations
0Matter, Journal Year: 2025, Volume and Issue: unknown, P. 102095 - 102095
Published: April 1, 2025
Language: Английский
Citations
0